noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

IRS - Internal Revenue Service

California man sentenced to 84 months in prison for marijuana[...]
IRS - Internal Revenue Service

Homeland Security Task Force indicts 18 defendants in wide-ranging drug[...]
IRS - Internal Revenue Service

Ten indicted in drug trafficking conspiracies in Homeland Security Task[...]

Healthcare

Hemab Therapeutics Holdings Inc.

05/11/2026 | Press release | Distributed by Public on 05/11/2026 14:01

Management Change/Compensation (Form 8-K)

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 8, 2026, Laura Tadvalkar, Ph.D., notified Hemab Therapeutics Holdings, Inc. (the "Company") of her decision to resign as a member of the Company's board of directors (the "Board"), effective immediately. Dr. Tadvalkar's resignation from the Board was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.

Hemab Therapeutics Holdings Inc. published this content on May 11, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 11, 2026 at 20:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]